SPHAERO
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
FR
EN
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
NP
Nirianne Palacpac
Publications (9)
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
Article scientifique · 2023
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
Article scientifique · 2022
Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population
Article scientifique · 2020
Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda
Article scientifique · 2020
Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda.
Article scientifique · 2020
Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda.
Article scientifique · 2019
A possible origin population of pathogenic intestinal nematodes, Strongyloides stercoralis, unveiled by molecular phylogeny
Article scientifique · 2017
Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda
Article scientifique · 2016
Application of a cell microarray chip system for accurate, highly sensitive and rapid diagnosis for malaria in Uganda
Article scientifique · 2016
Domaines principaux
Sciences de la santé
8
Sciences de la Terre et de l'environnement
1
Statistiques
Consultations
18
Téléchargements
0
Votre avis compte
Une suggestion, un bug, un ressenti sur SPHAERO ? Une minute suffit.
Plus tard
Donner mon avis
Votre avis compte
Nom
(optionnel)
Courriel
(optionnel)
Type de retour
Suggestion
Avis général
Signaler un bug
Message
Annuler
Envoyer
Merci, votre message a bien été envoyé.